Patents by Inventor Kristen D. Starbuck

Kristen D. Starbuck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002537
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: November 7, 2022
    Publication date: January 4, 2024
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Publication number: 20240003889
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: November 7, 2022
    Publication date: January 4, 2024
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Julie DeSander, Jeffrey Behrens, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Publication number: 20230022411
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: March 16, 2022
    Publication date: January 26, 2023
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Julie DeSander, Jeffrey Behrens, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Publication number: 20230029085
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: March 16, 2022
    Publication date: January 26, 2023
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Publication number: 20200041517
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: June 10, 2016
    Publication date: February 6, 2020
    Applicants: Seattle Genetics, Inc., The General Hospital Corporation
    Inventors: David A. EAVARONE, Julie DeSANDER, Jeffrey BEHRENS, Bo R. RUEDA, Rosemary FOSTER, Kristen D. STARBUCK
  • Publication number: 20190031780
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: January 27, 2017
    Publication date: January 31, 2019
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck